Mass spectrometric analysis to unravel the venom proteome composition of Indian snakes: opening new avenues in clinical research

References

• Mohapatra B, Warrell DA, Suraweera W, et al. Snakebite mortality in India: a nationally representative mortality survey. PLoS Negl Trop. 2011;5(4):e1018.
   PubMed Web of Science ®Google Scholar
• WHO. Snakebite envenoming: a strategy for prevention and control: executive summary. World Health Organization; 2019. Report no.:WHO/CDS/NTD/NZD/2019.03.
   Google Scholar
• Whitaker R, Martin G. Diversity and distribution of medically important snakes of India. In: Gopalakrishnakone P, Faiz A, Fernando R, Gnanathasan C, Habib A, Yang CC, editors. Toxinology (Vol. 2):Clinic Toxinol Asia Pac Afri. Dordrecht: Springer;2015;115–136.
   Google Scholar
• Mukherjee AK, Maity CR. Biochemical composition, lethality and pathophysiology of venom from two cobras – Naja naja and N. kaouthia. Comp Biochem Physiol B Biochem Mol Biol. 2002;131(2):125–132.
   PubMed Web of Science ®Google Scholar
• Chanda A, Patra A, Kalita B, et al. Proteomics analysis to compare the venom composition between Naja naja and Naja kaouthia from the same geographical location of eastern India: correlation with pathophysiology of envenomation and immunological cross-reactivity towards commercial polyantivenom. Expert Rev Proteomics. 2018;15(11):949–961.
   PubMed Web of Science ®Google Scholar
• Senji Laxme RR, Khochare S, de Souza HF, et al. Beyond the ‘Big Four’: venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies. PLoS Negl Trop Dis. 2019;13(12):e0007899.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK, Kalita B, Dutta S, et al. Snake envenomation: therapy and challenges in India. In: Section V: global approaches to envenomation and treatments. In: Mackessey SP, editor. Handbook of venoms and toxins of reptiles. Second ed. UK: CRC Press; 2020. (accepted manuscript).
   Google Scholar
• Punde DP. Management of snake-bite in rural Maharashtra: a 10-year experience. Natl Med J India. 2005;18(2):71–75.
   PubMed Web of Science ®Google Scholar
• Simpson ID. Snakebite management in India, the first few hours: a guide for primary care physicians. J Indian Med Assoc. 2007;105(6):324, 326, 328. passim.
   Google Scholar
• Salve PS, Vatavati S, Hallad J. Clustering the envenoming of snakebite in India: the district level analysis using Health Management Information System data. Clinic Epidemiol Global Health. 2020;8(3):733-738.
   Web of Science ®Google Scholar
• Jayanthi G, Gowda TV. Geographical variation in India in the composition and lethal potency of Russell’s viper (Vipera russelli) venom. Toxicon. 1988;26(3):257–264.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Maity C. The composition of Naja naja venom samples from three districts of West Bengal, India. Comp Biochem Physiol A. 1998;119(2):621–627.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Ghosal S, Maity C. Some biochemical properties of Russell’s viper (Daboia russelli) venom from Eastern India: correlation with clinico-pathological manifestation in Russell’s viper bite. Toxicon. 2000;38(2):163–175.
   PubMed Web of Science ®Google Scholar
• Shashidharamurthy R, Jagadeesha D, Girish K, et al. Variation in biochemical and pharmacological properties of Indian cobra (Naja naja naja) venom due to geographical distribution. Mol Cell Biochem. 2002;229(1–2):93–101.
   PubMed Web of Science ®Google Scholar
• Prasad NB, Uma B, Bhatt SK, et al. Comparative characterisation of Russell’s viper (Daboia/Vipera russelli) venoms from different regions of the Indian peninsula. Biochim Biophys Acta (BBA). 1999;1428(2–3):121–136.
   PubMed Web of Science ®Google Scholar
• Kalita B, Mackessy SP, Mukherjee AK. Proteomic analysis reveals geographic variation in venom composition of Russell’s viper in the Indian subcontinent: implications for clinical manifestations post-envenomation and antivenom treatment. Expert Rev Proteomics. 2018;15(10):837–849.
   PubMed Web of Science ®Google Scholar
• Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem. 1988 Oct 15;60(20):2299–2301.
   PubMed Web of Science ®Google Scholar
• Fenn JB, Mann M, Meng CK, et al. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64–71.
   PubMed Web of Science ®Google Scholar
• Breker M, Schuldiner M. The emergence of proteome-wide technologies: systematic analysis of proteins comes of age. Nat Rev Mol Cell Biol. 2014;15(7):453–464.
   PubMed Web of Science ®Google Scholar
• Lomonte B, Calvete JJ. Strategies in ‘snake venomics’ aiming at an integrative view of compositional, functional, and immunological characteristics of venoms. J Venom Animals Toxins Includ Trop Dis. 2017;23(1):26.
   PubMed Web of Science ®Google Scholar
• Kalita B, Mukherjee AK. Recent advances in snake venom proteomics research in India: a new horizon to decipher the geographical variation in venom proteome composition and exploration of candidate drug prototypes. J Prot Proteom. 2019; 10:149–164.
   Google Scholar
• Juarez P, Sanz L, Calvete JJ. Snake venomics: characterization of protein families in Sistrurus barbouri venom by cysteine mapping, N-terminal sequencing, and tandem mass spectrometry analysis. Proteomics. 2004;4(2):327–338.
   PubMed Web of Science ®Google Scholar
• Calvete JJ. Snake venomics – from low-resolution toxin-pattern recognition to toxin-resolved venom proteomes with absolute quantification. Expert Rev Proteomics. 2018;15(7):555–568.
   PubMed Web of Science ®Google Scholar
• Chanda A, Kalita B, Patra A, et al. Proteomic analysis and antivenomics study of western India Naja naja venom: correlation between venom composition and clinical manifestations of cobra bite in this region. Expert Rev Proteomics. 2018;16(2):171–184.
   PubMed Web of Science ®Google Scholar
• Dutta S, Chanda A, Kalita B, et al. Proteomic analysis to unravel the complex venom proteome of eastern India Naja naja: correlation of venom composition with its biochemical and pharmacological properties. J Proteomics. 2017;156:29–39.
   PubMed Web of Science ®Google Scholar
• Kalita B, Patra A, Mukherjee AK. Unraveling the proteome composition and immuno-profiling of western India Russell’s viper venom for in-depth understanding of its pharmacological properties, clinical manifestations, and effective antivenom treatment. J Proteome Res. 2017;16(2):583–598.
   PubMed Web of Science ®Google Scholar
• Kalita B, Patra A, Das A, et al. Proteomic analysis and immuno-profiling of eastern India Russell’s viper (Daboia russelii) venom: correlation between RVV composition and clinical manifestations post RV bite. J Proteome Res. 2018;17(8):2819–2833.
   PubMed Web of Science ®Google Scholar
• Kalita B, Singh S, Patra A, et al. Quantitative proteomic analysis and antivenom study revealing that neurotoxic phospholipase A2 enzymes, the major toxin class of Russell’s viper venom from southern India, shows the least immuno-recognition and neutralization by commercial polyvalent antivenom. Int J Biol Macromol. 2018;118:375–385.
   PubMed Web of Science ®Google Scholar
• Patra A, Kalita B, Chanda A, et al. Proteomics and antivenomics of Echis carinatus carinatus venom: correlation with pharmacological properties and pathophysiology of envenomation. Sci Rep. 2017;7(1):17119.
   PubMedGoogle Scholar
• Patra A, Chanda A, Mukherjee AK. Quantitative proteomic analysis of venom from southern India common krait (Bungarus caeruleus) and identification of poorly immunogenic toxins by immune-profiling against commercial antivenom. Expert Rev Proteomics. 2019;16(5):457–469.
   PubMed Web of Science ®Google Scholar
• Sharma M, Das D, Iyer JK, et al. Unveiling the complexities of Daboia russelii venom, a medically important snake of India, by tandem mass spectrometry. Toxicon. 2015;107:266–281.
   PubMed Web of Science ®Google Scholar
• Choudhury M, McCleary RJ, Kesherwani M, et al. Comparison of proteomic profiles of the venoms of two of the ‘Big Four’ snakes of India, the Indian cobra (Naja naja) and the common krait (Bungarus caeruleus), and analyses of their toxins. Toxicon. 2017;135:33–42.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK, Kalita B, Mackessy SP. A proteomic analysis of Pakistan Daboia russelii russelii venom and assessment of potency of Indian polyvalent and monovalent antivenom. J Proteomics. 2016;144:73–86.
   PubMed Web of Science ®Google Scholar
• Tan NH, Fung SY, Tan KY, et al. Functional venomics of the Sri Lankan Russell’s viper (Daboia russelii) and its toxinological correlations. J Proteomics. 2015;128:403–423.
   PubMed Web of Science ®Google Scholar
• Sintiprungrat K, Watcharatanyatip K, Senevirathne W, et al. A comparative study of venomics of Naja naja from India and Sri Lanka, clinical manifestations and antivenomics of an Indian polyspecific antivenom. J Proteomics. 2016;132:131–143.
   PubMed Web of Science ®Google Scholar
• Ali SA, Yang DC, Jackson TN, et al. Venom proteomic characterization and relative antivenom neutralization of two medically important Pakistani elapid snakes (Bungarus sindanus and Naja naja). J Proteomics. 2013;89:15–23.
   PubMed Web of Science ®Google Scholar
• Chanda A, Mukherjee AK. Quantitative proteomics to reveal the composition of southern India spectacled cobra (Naja naja) venom and its immunological cross-reactivity towards commercial antivenom. Int J Biol Macromol. 2020;160:224-232. .
   PubMed Web of Science ®Google Scholar
• Wong KY, Tan CH, Tan KY, et al. Elucidating the biogeographical variation of the venom of Naja naja (spectacled cobra) from Pakistan through a venom-decomplexing proteomic study. J Proteomics. 2018;175:156–173.
   PubMed Web of Science ®Google Scholar
• Asad MH, McCleary RJ, Salafutdinov I, et al. Proteomics study of southern Punjab Pakistani cobra (Naja naja: formerly Naja naja karachiensis) venom. Toxicol Env Chem. 2019;101(1–2):91–116.
   Web of Science ®Google Scholar
• Faisal T, Tan KY, Sim SM, et al. Proteomics, functional characterization and antivenom neutralization of the venom of Pakistani Russell’s viper (Daboia russelii) from the wild. J Proteomics. 2018;183:1–13.
   PubMed Web of Science ®Google Scholar
• Pla D, Sanz L, Quesada-Bernat S, et al. Phylovenomics of Daboia russelii across the Indian subcontinent. Bioactivities and comparative in vivo neutralization and in vitro third-generation antivenomics of antivenoms against venoms from India, Bangladesh and Sri Lanka. J Proteomics. 2019;207:103443.
   PubMed Web of Science ®Google Scholar
• Hashmi SU, Alvi A, Munir I, et al. Functional venomics of the Big-4 snakes of Pakistan. Toxicon. 2020;179:60‐71.
   PubMed Web of Science ®Google Scholar
• Vanuopadath M, Sajeev N, Murali AR, et al. Mass spectrometry-assisted venom profiling of Hypnale hypnale found in the Western Ghats of India incorporating de novo sequencing approaches. Int J Biol Macromol. 2018;118(Pt B):1736–1746.
   PubMedGoogle Scholar
• Vanuopadath M, Shaji SK, Raveendran D, et al. Delineating the venom toxin arsenal of Malabar pit viper (Trimeresurus malabaricus) from the Western Ghats of India and evaluating its immunological cross-reactivity and in vitro cytotoxicity. Int J Biol Macromol. 2020;148:1029–1045.
   PubMed Web of Science ®Google Scholar
• Deka A, Gogoi A, Das D, et al. Proteomics of Naja kaouthia venom from North East India and assessment of Indian polyvalent antivenom by third generation antivenomics. J Proteomics. 2019;207:103463.
   PubMed Web of Science ®Google Scholar
• Deka A, Reza MA, Faisal Hoque KM, et al. Comparative analysis of Naja kaouthia venom from north-east India and Bangladesh and its cross reactivity with Indian polyvalent antivenoms. Toxicon. 2019;164:31–43.
   PubMed Web of Science ®Google Scholar
• Tsai IH, Lu PJ, Su JC. Two types of Russell’s viper revealed by variation in phospholipases A2 from venom of the subspecies. Toxicon. 1996;34(1):99–109.
   PubMed Web of Science ®Google Scholar
• Shashidharamurthy R, Mahadeswaraswamy YH, Ragupathi L, et al. Systemic pathological effects induced by cobra (Naja naja) venom from geographically distinct origins of Indian peninsula. Exp Toxicol Pathol. 2010;62(6):587–592.
   PubMedGoogle Scholar
• Bawaskar HS, Bawaskar PH, Punde DP, et al. Profile of snakebite envenoming in rural Maharashtra, India. J Assoc Physicians India. 2008;56:88–95.
   PubMedGoogle Scholar
• Kini RM, Doley R. Structure, function and evolution of three-finger toxins: mini proteins with multiple targets. Toxicon. 2010;56(6):855–867.
   PubMed Web of Science ®Google Scholar
• Utkin YN. Last decade update for three-finger toxins: newly emerging structures and biological activities. World J Biol Chem. 2019 7;10(1):17–27.
   PubMedGoogle Scholar
• Schetinger M, Rocha J, Ahmed M, et al. Snake venom acetylcholinesterase. In: Mackessey SP, editor. Handbook Venoms Toxins Rept. London: CRC Press; 2009;207–219.
   Google Scholar
• Bawaskar HS, Bawaskar PH, Bawaskar PH. Snake bite in India: a neglected disease of poverty. Lancet. 2017;390(10106):1947–1948.
   PubMed Web of Science ®Google Scholar
• Chiappinelli V, Hue B, Mony L, et al. Kappa-bungarotoxin blocks nicotinic transmission at an identified invertebrate central synapse. J Expt Biology. 1989;141(1):61–71.
   PubMedGoogle Scholar
• Pung YF, Wong PT, Kumar PP, et al. Ohanin, a novel protein from king cobra venom, induces hypolocomotion and hyperalgesia in mice. J Bio Chem. 2005;280(13):13137–13147.
   PubMed Web of Science ®Google Scholar
• Maroko PR, Carpenter CB, Chiariello M, et al. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest. 1978;61(3):661–670.
   PubMed Web of Science ®Google Scholar
• Montecucco C, Gutierrez JM, Lomonte B. Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action. Cell Mol Life Sci. 2008;65(18):2897–2912.
   PubMed Web of Science ®Google Scholar
• Gutiérrez JM, Theakston RDG, Warrell DA. Confronting the neglected problem of snake bite envenoming: the need for a global partnership. PLoS Med. 2006;3(6):e150.
   PubMed Web of Science ®Google Scholar
• Oh AMF, Tan CH, Ariaranee GC, et al. Venomics of Bungarus caeruleus (Indian krait): comparable venom profiles, variable immunoreactivities among specimens from Sri Lanka, India and Pakistan. J Proteomics. 2017;164:1–18.
   PubMed Web of Science ®Google Scholar
• Theakston RD, Phillips RE, Warrell DA, et al. Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkine antivenom. Trans R Soc Trop Med Hyg. 1990;84(2):301–308.
   PubMed Web of Science ®Google Scholar
• Bawaskar HS, Bawaskar PH, Bawaskar PH. Pathophysiology of dilatation of pupils due to scorpion and snake envenomation and its therapeutic value: clinical observations. Indian J Ophthalmol. 2017;65(1):67.
   PubMed Web of Science ®Google Scholar
• Doley R, Mukherjee AK. Purification and characterization of an anticoagulant phospholipase A(2) from Indian monocled cobra (Naja kaouthia) venom. Toxicon. 2003;41(1):81–91.
   PubMed Web of Science ®Google Scholar
• Sun QY, Bao J. Purification, cloning and characterization of a metalloproteinase from Naja atra venom. Toxicon. 2010;56(8):1459–1469.
   PubMed Web of Science ®Google Scholar
• Joseph J, Simpson I, Menon N, et al. First authenticated cases of life-threatening envenoming by the hump-nosed pit viper (Hypnale hypnale) in India. Trans R Soc Trop Med Hyg. 2007;101(1):85–90.
   PubMed Web of Science ®Google Scholar
• Suntravat M, Yusuksawad M, Sereemaspun A, et al. Effect of purified Russell’s viper venom-factor X activator (RVV-X) on renal hemodynamics, renal functions, and coagulopathy in rats. Toxicon. 2011;58(3):230–238.
   PubMed Web of Science ®Google Scholar
• De Toni LG, Menaldo DL, Cintra AC, et al. Inflammatory mediators involved in the paw edema and hyperalgesia induced by batroxase, a metalloproteinase isolated from Bothrops atrox snake venom. Int Immunopharmacol. 2015;28(1):199–207.
   PubMed Web of Science ®Google Scholar
• Teixeira C, Cury Y, Moreira V, et al. Inflammation induced by Bothrops asper venom. Toxicon. 2009;54(7):988–997.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK. A major phospholipase A2 from Daboia russelii russelii venom shows potent anticoagulant action via thrombin inhibition and binding with plasma phospholipids. Biochimie. 2014;99:153–161.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK. The pro-coagulant fibrinogenolytic serine protease isoenzymes purified from Daboia russelii russelii venom coagulate the blood through factor V activation: role of glycosylation on enzymatic activity. PLoS One. 2014;9(2):e86823.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK, Mackessy SP. Biochemical and pharmacological properties of a new thrombin-like serine protease (Russelobin) from the venom of Russell’s viper (Daboia russelii russelii) and assessment of its therapeutic potential. Biochim Biophys Acta (BBA) Gen Sub. 2013;1830(6):3476–3488.
   PubMed Web of Science ®Google Scholar
• Thakur R, Mukherjee A. A brief appraisal on Russell’s viper venom (Daboia russelii russelii) proteinases.In: Gopalakrishnakone P, Inagaki H, Mukherjee AK, Rahmy TR, Vogel CW editors. Handbook Toxinol: Snake Venoms: Netherlands: Springer Nature; 2015;123–144.
   Google Scholar
• Mukherjee AK, Dutta S, Mackessy SP. A new C-type lectin (RVsnaclec) purified from venom of Daboia russelii russelii shows anticoagulant activity via inhibition of FXa and concentration-dependent differential response to platelets in a Ca2+-independent manner. Thromb Res. 2014;134(5):1150–1156.
   PubMed Web of Science ®Google Scholar
• Saikia D, Bordoloi NK, Chattopadhyay P, et al. Differential mode of attack on membrane phospholipids by an acidic phospholipase A2 (RVVA-PLA2-I) from Daboia russelli venom. Biochim Biophys Acta (BBA) -Biomemb. 2012;1818(12):3149–3157.
   PubMed Web of Science ®Google Scholar
• Morais IC, Pereira GJ, Orzáez M, et al. L-Aminoacid oxidase from Bothrops leucurus venom induces nephrotoxicity via apoptosis and necrosis. PloS One. 2015;10:7.
   Web of Science ®Google Scholar
• Yamazaki Y, Matsunaga Y, Tokunaga Y, et al. Snake venom vascular endothelial growth factors (VEGF-Fs) exclusively vary their structures and functions among species. J Bio Chem. 2009;284(15):9885–9891.
   PubMed Web of Science ®Google Scholar
• Suchithra N, Pappachan J, Sujathan P. Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes. Emer Med J. 2008;25(4):200–204.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK, Dutta S, Kalita B, et al. Structural and functional characterization of complex formation between two Kunitz-type serine protease inhibitors from Russell’s viper venom. Biochimie. 2016;128:138–147.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK, Mackessy SP. Pharmacological properties and pathophysiological significance of a Kunitz-type protease inhibitor (Rusvikunin-II) and its protein complex (Rusvikunin complex) purified from Daboia russelii russelii venom. Toxicon. 2014;89:55–66.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK. Non-covalent interaction of phospholipase A2 (PLA2) and kaouthiotoxin (KTX) from venom of Naja kaouthia exhibits marked synergism to potentiate their cytotoxicity on target cells. J Venom Res. 2010;1:37.
   PubMedGoogle Scholar
• Doley R, Kini RM. Protein complexes in snake venom. Cell Mol Life Sci. 2009;66(17):2851–2871.
   PubMed Web of Science ®Google Scholar
• Kumar JR, Basavarajappa BS, Arancio O, et al. Isolation and characterization of “Reprotoxin”, a novel protein complex from Daboia russelii snake venom. Biochimie. 2008;90(10):1545–1559.
   PubMed Web of Science ®Google Scholar
• Dutta S, Sinha A, Dasgupta S, et al. Binding of a Naja naja venom acidic phospholipase A2 cognate complex to membrane-bound vimentin of rat L6 cells: implications in cobra venom-induced cytotoxicity. Biochim Biophys Acta (BBA) -Biomemb. 2019;1861(5):958–977.
   PubMed Web of Science ®Google Scholar
• Maduwage K, Silva A, O’Leary MA, et al. Efficacy of Indian polyvalent snake antivenoms against Sri Lankan snake venoms: lethality studies or clinically focussed in vitro studies. Sci Rep. 2016;6:26778.
   PubMed Web of Science ®Google Scholar
• Kumar AV, Gowda TV. Novel non-enzymatic toxic peptide of Daboia russelii (Eastern region) venom renders commercial polyvalent antivenom ineffective. Toxicon. 2006;47(4):398–408.
   PubMed Web of Science ®Google Scholar
• Calvete JJ, Rodriguez Y, Quesada-Bernat S, et al. Toxin-resolved antivenomics-guided assessment of the immunorecognition landscape of antivenoms. Toxicon. 2018;148:107–122.
   PubMed Web of Science ®Google Scholar
• Thakur R, Mukherjee AK. Pathophysiological significance and therapeutic applications of snake venom protease inhibitors. Toxicon. 2017;131:37–47.
   PubMed Web of Science ®Google Scholar
• White J. Snake venoms and coagulopathy. Toxicon. 2005;45(8):951–967.
   PubMed Web of Science ®Google Scholar
• Kemparaju K, Krishnakanth TP, Veerabasappa Gowda T. Purification and characterization of a platelet aggregation inhibitor acidic phospholipase A2 from Indian saw-scaled viper (Echis carinatus) venom. Toxicon. 1999;37(12):1659–1671.
   PubMed Web of Science ®Google Scholar
• Jagadeesha DK, Shashidhara Murthy R, Girish KS, et al. A non-toxic anticoagulant metalloprotease: purification and characterization from Indian cobra (Naja naja naja) venom. Toxicon. 2002;40(6):667–675.
   PubMed Web of Science ®Google Scholar
• Saikia D, Thakur R, Mukherjee AK. An acidic phospholipase A2 (RVVA-PLA2-I) purified from Daboia russelli venom exerts its anticoagulant activity by enzymatic hydrolysis of plasma phospholipids and by non-enzymatic inhibition of factor Xa in a phospholipids/Ca2+ independent manner. Toxicon. 2011;57(6):841–850.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK, Mackessy SP, Dutta S. Characterization of a Kunitz-type protease inhibitor peptide (Rusvikunin) purified from Daboia russelii russelii venom. Int J Biol Macromol. 2014;67:154–162.
   PubMed Web of Science ®Google Scholar
• Thakur R, Chattopadhyay P, Mukherjee AK. The wound healing potential of a pro-angiogenic peptide purified from Indian Russell’s viper (Daboia russelii) venom. Toxicon. 2019;165:78–82.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK, Saviola AJ, Burns PD, et al. Apoptosis induction in human breast cancer (MCF-7) cells by a novel venom L-amino acid oxidase (Rusvinoxidase) is independent of its enzymatic activity and is accompanied by caspase-7 activation and reactive oxygen species production. Apoptosis. 2015;20(10):1358–1372.
   PubMed Web of Science ®Google Scholar
• Gomes A, Choudhury SR, Saha A, et al. A heat stable protein toxin (drCT-I) from the Indian viper (Daboia russelli russelli) venom having antiproliferative, cytotoxic and apoptotic activities. Toxicon. 2007;49(1):46–56.
   PubMed Web of Science ®Google Scholar
• Mukherjee AK, Saikia D, Thakur R. Medical and diagnostic applications of snake venom proteomes. J Prot Proteom. 2013;2:1.
   Google Scholar